BOSTON — Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy […]
Oxford Nanopore Technologies today announced that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific Officer, effective immediately. Rosemary and Lakmal succeed Clive Brown, Chief Officer of Technology, Innovation, and Products, who has stepped down to pursue new projects. Clive will be […]
CAPE TOWN, South Africa — MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent’s first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum […]
LONDON — SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment of Ron Andrews, Founder and Managing Partner of Bethesda Group Advisors, to its Board of Directors as a Non-Executive Director. During more than 35 years of strategic leadership in the Life Sciences Tools and Molecular Diagnostics sectors, Mr Andrews […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO […]
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end […]
WALTHAM, Mass. — Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative. The Somatic Reference Samples (SRS) Initiative is a public-private partnership convened and […]
License enables Dyadic Applied BioSolutions to expand genetic engineering capabilities Dublin, Ireland, and Jupiter FL, USA: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions (‘Dyadic’), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced they have signed a non-exclusive agreement granting access to ERS’ foundational […]
Following global commercial launch in September, Illumina Protein Prep’s “out of the box” solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exceptional […]
Oxford, UK – Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) – the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of expertise in hybrid capture technology, the panel detects ultra-low frequency variants in key MRD-associated biomarkers in acute myeloid leukaemia (AML). This means users […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
